These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10632048)
1. Aromatic carboxylic acids as farnesyl surrogates in farnesylpyrophosphate-based farnesyltransferase inhibitors. Schlitzer M; Sattler I Bioorg Med Chem; 1999 Nov; 7(11):2391-5. PubMed ID: 10632048 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate. Schlitzer M; Böhm M; Sattler I; Dahse HM Bioorg Med Chem; 2000 Aug; 8(8):1991-2006. PubMed ID: 11003144 [TBL] [Abstract][Full Text] [Related]
3. Non-thiol farnesyltransferase inhibitors: the concept of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors. Schlitzer M; Sattler I Eur J Med Chem; 2000; 35(7-8):721-6. PubMed ID: 10960188 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of N-acylaspartic acid dimethyl esters. Schlitzer M; Sattler I; Dahse HM Anticancer Res; 1999; 19(3A):2117-20. PubMed ID: 10470158 [TBL] [Abstract][Full Text] [Related]
5. Non-peptidic, non-prenylic bisubstrate farnesyltransferase inhibitors. Part 3: structural requirements of the central moiety for farnesyltransferase inhibitory activity. Schlitzer M; Böhm M; Sattler I Bioorg Med Chem; 2000 Oct; 8(10):2399-406. PubMed ID: 11058034 [TBL] [Abstract][Full Text] [Related]
7. Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones. Mitsch A; Böhm M; Wissner P; Sattler I; Schlitzer M Bioorg Med Chem; 2002 Aug; 10(8):2657-62. PubMed ID: 12057654 [TBL] [Abstract][Full Text] [Related]
8. Non-thiol farnesyltransferase inhibitors: evaluation of different AA(X)-peptidomimetic substructures in combination with arylic cysteine replacements. Sakowski J; Böhm M; Sattler I; Schlitzer M Arch Pharm (Weinheim); 2002 Apr; 335(4):135-42. PubMed ID: 12112033 [TBL] [Abstract][Full Text] [Related]
9. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones. Mitsch A; Böhm M; Sattler I; Schlitzer M Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081 [TBL] [Abstract][Full Text] [Related]
10. Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors. Schlitzer M Curr Pharm Des; 2002; 8(19):1713-22. PubMed ID: 12171543 [TBL] [Abstract][Full Text] [Related]
16. 3-Aryl-4-aryloyl-1-(1H-imidazol-5-yl)methylpyrrole, a novel class of farnesyltransferase inhibitors. Lee H; Lee J; Shin Y; Jung W; Kim JH; Park K; Ro S; Chung HH; Koh JS Bioorg Med Chem Lett; 2001 Nov; 11(22):2963-5. PubMed ID: 11677136 [TBL] [Abstract][Full Text] [Related]